Differences in insulin clearance between metabolically healthy and unhealthy obese subjects

Acta Diabetologica

Volumn 51, Issue 2, 2014, Pages 257-261

  Marini, Maria A ^a   Frontoni, Simona ^a   Succurro, Elena ^b   Arturi, Franco ^b   Fiorentino, Teresa V ^b   Sciacqua, Angela ^b   Perticone, Francesco ^b   Sesti, Giorgio ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Insulin clearance; Insulin resistance; Metabolically healthy obese; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C PEPTIDE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; INSULIN; TRIACYLGLYCEROL; CHOLESTEROL;

ADULT; ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FAT MASS; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLICALLY ABNORMAL OBESE; METABOLICALLY HEALTHY OBESE; OBESITY; PRIORITY JOURNAL; WAIST CIRCUMFERENCE; BLOOD; CHI SQUARE DISTRIBUTION; GLUCOSE CLAMP TECHNIQUE; INSULIN RESISTANCE; PHYSIOLOGY;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; C-PEPTIDE; CHI-SQUARE DISTRIBUTION; CHOLESTEROL; CROSS-SECTIONAL STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; OBESITY; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84898449658     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-013-0511-9     Document Type: Article

References (37)

1. Wildman RP, Muntner P, Reynolds K et al (2008) The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 168:1617-1624
2. Messier V, Karelis AD, Prud'homme D et al (2010) Identifying metabolically healthy but obese individuals in sedentary postmenopausal women. Obesity 18:911-917
3. Brochu M, Tchernof A, Dionne IJ et al (2001) What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 86:1020-1025
4. Karelis AD, St-Pierre DH, Conus F et al (2004) Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 89:2569-2575
5. Karelis AD, Faraj M, Bastard JP et al (2005) The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 90:4145-4150
6. Marini MA, Succurro E, Frontoni S et al (2007) Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy non-obese women and obese insulin resistant women. Diabetes Care 30:2145-2147
7. Stefan N, Kantartzis K, Machann J et al (2008) Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168:1609-1616
8. Succurro E, Marini MA, Frontoni S et al (2008) Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity 16:1881-1886
9. Aguilar-Salinas CA, García EG, Robles L et al (2008) High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab 93:4075-4079
10. Messier V, Karelis AD, Robillard ME et al (2010) Metabolically healthy but obese individuals: relationship with hepatic enzymes. Metabolism 59:20-24
11. Sesti G, Folli F, Perego L et al (2011) Effects of weight loss in metabolically healthy obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. PLoS One 6(3):e17737
12. Khan UI, Wang D, Thurston RC et al (2011) Burden of subclinical cardiovascular disease in "metabolically benign" and "at-risk" overweight and obese women: the Study of Women's Health Across the Nation (SWAN). Atherosclerosis 217:179-186
13. Sesti G, Succurro E, Arturi F et al (2011) IGF-1 levels link estimated glomerular filtration rate to insulin resistance in obesity: a study in obese, but metabolically healthy, subjects and obese, insulin-resistant subjects. Nutr Metab Cardiovasc Dis 21:933-940
14. Meigs JB, Wilson PW, Fox CS et al (2006) Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 91:2906-2912
15. Arnlöv J, Ingelsson E, Sundström J et al (2010) Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 121:230-236
16. Calori G, Lattuada G, Piemonti L et al (2011) Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 34:210-215
17. Hamer M, Stamatakis E (2012) Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 97:2482-2488
18. Ogorodnikova AD, Kim M, McGinn AP et al (2012) Incident cardiovascular disease events in metabolically benign obese individuals. Obesity 20:651-659
19. Appleton SL, Seaborn CJ, Visvanathan R et al (2013) Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care March 14 [Epub ahead of print]
20. Duckworth WC, Bennett RG, Hamel FG (1997) The significance of intracellular insulin to insulin action. J Investig Med 45:20-27
21. Farris W, Mansourian S, Chang Y et al (2003) Insulin degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 100:4162-4167
22. Abdul-Hay SO, Kang D, McBride M et al (2011) Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance. PLoS One 6:e20818
23. Faber OK, Christensen K, Kehlet H et al (1981) Decreased insulin removal contributes to hyperinsulinemia in obesity. J Clin Endocrinol Metab 53:618-621
24. Bonora E, Zavaroni I, Bruschi F et al (1984) Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism? J Clin Endocrinol Metab 59:1121-1127
25. Erdmann J, Mayr M, Oppel U et al (2009) Weight-dependent differential contribution of insulin secretion and clearance to hyperinsulinemia of obesity. Regul Pept 152:1-7
26. Jones CN, Abbasi F, Carantoni M et al (2000) Roles of insulin resistance and obesity in regulation of plasma insulin concentrations. Am J Physiol Endocrinol Metab 278:E501-E508
27. Peiris AN, Mueller RA, Smith GA et al (1986) Splanchnic insulin metabolism in obesity. Influence of body fat distribution. J Clin Invest 78:1648-1657
28. Kotronen A, Vehkavaara S, Seppälä-Lindroos A et al (2007) Effect of liver fat on insulin clearance. Am J Physiol Endocrinol Metab 293:E1709-E1715
29. Mittelman SD, Van Citters GW, Kim SP et al (2000) Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced β cell response. Diabetes 49:2116-2125
30. Laakso M, Zilinskaite J, Hansen T et al (2008) Insulin sensitivity, insulin release and GLP-1 levels in subjects with IFG and/or IGT in the EUGENE2 study. Diabetologia 51:502-511
31. Marini MA, Frontoni S, Mineo D et al (2003) The Arg972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients. J Clin Endocrinol Metab 88:3368-3371
32. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab Gastrointest Physiol 237:E214-E223
33. Kahn SE (2001) The importance of β-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 86:4047-4058
34. Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640-1645
35. Svedberg J, Björntorp P, Smith U, Lönnroth P (1990) Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 39:570-574
36. Wiesenthal SR, Sandhu H, McCall RH et al (1999) Free fatty acids impair hepatic insulin extraction in vivo. Diabetes 48:766-774
37. Balent B, Goswami G, Goodloe G et al (2002) Acute elevation of NEFA causes hyperinsulinemia without effect on insulin secretion rate in healthy human subjects. Ann NY Acad Sci 967:535-543